PBAC Public Summary Documents - July 2011
Public summary documents relating to the July 2011 PBAC meeting
Page last updated: 28 May 2013
- Abatacept, powder for I.V. infusion, 250 mg, Orencia® - July 2011
- Agomelatine, tablet, 25 mg, Valdoxan® - July 2011
- Alendronate Sodium, tablet equivalent to 70 mg alendronic acid, Fosamax® Once Weekly; ALENDRONATE SODIUM with Colecalciferol, tablet equivalent to 70 mg alendronic acid with 70 micrograms colecalciferol, Fosamax Plus™; Alendronate Sodium with Colecalciferol tablet equivalent to 70 mg alendronic acid with 140 micrograms colecalciferol, Fosamax Plus™ 70 mg/140 mcg; Alendronate Sodium with Colecalciferol and Calciuum Carbonate, pack containing 4 tablets containing the equivalent of 70 mg alendronic acid with 140 micrograms colecalciferol and 48 tablets calcium carbonate 1.25 g (equivalent to 500 mg elemental calcium), Fosamax Plus D-Cal® - July 2011
- Alglucosidase Alfa, powder for I.V. infusion, 50 mg, Myozyme® - July 2011
- Apixaban, tablet 2.5 mg, Eliquis® - July 2011
- Asenapine (bipolar), sublingual wafer, 5 mg and 10 mg (as maleate), Saphris® - July 2011
- Asenapine (schizophrenia), sublingual wafer, 5 mg and 10 mg (as maleate), Saphris® - July 2011
- Boceprevir, capsule 200 mg, Victrelis® - July 2011
- Bortezomib, powder for injection, 1 mg (solvent required), Velcade® - July 2011
- Cabazitaxel, injection set containing 1 single use vial concentrate for I.V. infusion, 60 mg (anhydrous) in 1.5 mL with 1 single use vial diluent 4.5 mL, Jevtana® - July 2011
- Clostridium botulinum type A toxin haemagglutinin complex, lyophilised powder for I.M. injection, 300 units and 500 units, Dysport® - July 2011
- Corifollitropin Alfa, solution for injection, 100 micrograms in 0.5 mL pre-filled syringe, 150 micrograms in 0.5 mL pre-filled syringe, Elonva® - July 2011
- Dasatinib, tablets, 20 mg, 50 mg, 70 mg and 100 mg, Sprycel® - July 2011
- Denosumab, solution for subcutaneous injection, 120 mg in 1.7 mL, Xgeva® - July 2011
- Diphtheria-tetanus-acellular pertussis (dTpa) vaccine, 0.5 mL in pre-filled syringe, Boostrix® - July 2011
- Exenatide, powder for injection, 2 mg, Bydureon® - July 2011
- Icatibant, injection, 30 mg in 3 mL (as acetate), single use pre-filled syringe, Firazyr® - July 2011
- Indacaterol, capsule containing powder for oral inhalation, 150 micrograms and 300 micrograms (as maleate), Onbrez® - July 2011
- Ipilimumab, concentrate solution for I.V. infusion, 50 mg in 10 mL, 200 mg in 40 mL, Yervoy® - July 2011
- Lenalidomide, capsules, 5 mg and 10 mg, Revlimid® - July 2011
- Linagliptin, tablet, 5 mg, Trajenta® - July 2011
- Nilotinib, capsule, 150 mg, Tasigna® - July 2011
- Rasagiline, tablet, 1 mg, Azilect® - July 2011
- Ribavirin, capsules, 200 mg, (84 or 112 capsules) with peginterferon alfa-2b, single use injection pens, 50, 80, 100 or 120 micrograms, Pegatron® - July 2011
- Somatropin (Recombinant human growth hormone), injection, 5 mg (15 i.u.) and 12 mg (36 i.u.) in 1 mL cartridge (with preservative), Genotropin® - July 2011
- Sunitinib malate, capsules, 12.5 mg, 25 mg and 50 mg (base), Sutent® - July 2011
- Ticagrelor, tablet, 90 mg, Brilinta® - July 2011
- Trastuzumab, powder for I.V. infusion, 60 mg and 150 mg, Herceptin® - July 2011
